Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Blackfinch Investments (Fund)
Blackfinch Ventures EIS Portfolios
2nd Dec 2024
Calculus Capital (Funds)
Calculus Knowledge Intensive EIS Fund 3
29th Nov 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
108: An all-star panel discuss EIS & VCTs in 2024 and look forward to 2025
Stay up-to-date with the latest research
Sign up to our newsletter
Latest research
Our research can be accessed for free under MIFID.
Find out more >
All research
Corporate research
- Update
- Monthly Report
- Sector Report
Tax advantaged research
- VCT
- EIS
- SEIS
- Initiation
- BR Review
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
List companies
Blackfinch Investments (Fund)
Financials
Blackfinch Ventures EIS Portfolios
By
Dr Brian Moretta
30 Sep 2019
Allergy Therapeutics plc
Life Sciences
Continuing to gain market share
26 Sep 2019
RM Secured Direct Lending
Financials
Defensive qualities in uncertain times
By
Mark Thomas
26 Sep 2019
DP Poland Plc
Consumer
FY19 interim results announced
By
Jason Streets
25 Sep 2019
Praetura Ventures Ltd
Praetura EIS 2020 Fund
By
Dr Brian Moretta
24 Sep 2019
City of London Investment Group
Financials
Another solid year
By
Dr Brian Moretta
18 Sep 2019
Filta Group
Services
FY19 interim results
By
Jason Streets
09 Sep 2019
Pantheon International Plc
Financials
11.9% average annual NAV growth since 1987
By
Mark Thomas
06 Sep 2019
Surface Transforms
Rapid acceleration – “game-change” announcements
By
Mike Foster
05 Sep 2019
The Monthly: September 2019
03 Sep 2019
Shield Therapeutics Plc
Life Sciences
FDA approval ushers in a new era for Shield
02 Sep 2019
Prev
1
...
52
53
54
55
56
...
84
Next
